Hyperparathyroidism is an increased parathyroid hormone (PTH) l... - dofaq.com

Hyperparathyroidism is an increased parathyroid hormone (PTH) l...

wikipedia - 19 Sep 2016
Hyperparathyroidism is an increased parathyroid hormone (PTH) levels in the blood. This occurs either from the parathyroid glands inappropriately making too much PTH (primary hyperparathyroidism) or other events triggering increased production by the parathyroid glands (secondary hyperparathyroidism). Most people with primary disease have no symptoms at the time of diagnosis. In those with symptoms the most common is kidney stones with other potential symptoms including weakness, depression, bone pai

Denosumab May Increase BMD in Women With Primary Hyperparathyroidism

Endocrinology Advisor - 16 Feb 2018
A significant increase in bone mineral density was more frequent in women with primary hyperparathyroidism than in women with primary osteoporosis. In older women with primary hyperparathyroidism (PHPT)-related osteoporosis, treatment with denosumab ...

Hyperparathyroidism Pipeline Research Report 2018

Facts of Week - 24 Feb 2018
Hyperparathyroidism- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for ...

FDA approves generic version of Amgen's Sensipar

Healio - 14 Mar 2018
The FDA has approved the first generic versions of Amgen's Sensipar to treat secondary hyperparathyroidism in patients on dialysis. The FDA's Center for Drug Evaluation and Research (CDER) announced the approval for the cinacalcet hydrochloride tables ...

What's New